NICE updates guidance on fever in young children

NICE updates guidance on fever in young children

August 14 2017 A number of changes have been made to the NICE guidelines and assessing and...

National measles guidelines published

National measles guidelines published

August 14 2017 Updated guidelines relating to measles identification, case management and control...

Wales recommits to supporting those affected by neurological conditions

Wales recommits to supporting those affected by neurological conditions

August 1 2017The Welsh Government has renewed its commitment to supporting people with...

Study indicates 11.8m people should be on statins

Study indicates 11.8m people should be on statins

August 3 2017 Millions of people are not being prescribed a statin despite NICE guidelines...

EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

June 29 2016 Adempas (riociguat) should not be used in patients with symptomatic pulmonary...

  • NICE updates guidance on fever in young children

    NICE updates guidance on fever in young children

    Monday, 14 August 2017 09:59
  • National measles guidelines published

    National measles guidelines published

    Monday, 14 August 2017 09:16
  • Wales recommits to supporting those affected by neurological conditions

    Wales recommits to supporting those affected by neurological conditions

    Saturday, 05 August 2017 13:54
  • Study indicates 11.8m people should be on statins

    Study indicates 11.8m people should be on statins

    Saturday, 05 August 2017 14:51
  • EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    Wednesday, 29 June 2016 10:44

pills in handMay 11 2016

Initiating antiepileptic drug therapy in someone who has had a first unprovoked seizure may not always be the best option, a Cochrane review has proposed.

Initiating an antiepileptic after a single unprovoked seizure appears to reduce the risk of a subsequent seizure. High quality evidence indicated there was a lower probability of seizure at a year and at five years, and a higher probability of five-year remission of seizures, said the researchers.

However, there was no evidence that antiepileptic treatment affected the overall mortality of epilepsy, and treatment of the first seizure “was associated with a significantly higher risk of adverse events.” In addition, “there is moderate quality evidence that immediate treatment may result in more side effects than delayed treatment, but it is unclear if immediate treatment results in more side effects than placebo or no treatment.”

The findings are drawn from a review of six studies, covering data from 1,634 participants, including those who had received immediate drug treatment after their first seizure. Primary outcomes were seizure recurrence and immediate remission for five years.

Among the secondary findings were that the median time to a second seizure occurring was 736 days in the control group, and 1,165 in patients who had been initiated on treatment after their first seizure. Two of the studies had also included reporting on deaths, but showed that time to death was not different between those initiated on antiepileptics and those in the control group.

“The decision to start antiepileptic drug treatment following a first seizure still remains a controversial issue,” said the researchers. “indiscriminate treatment following a first unprovoked seizure is not warranted, since the risk of recurrence must be balanced against the likelihood to attain five-year remission during the follow-up and the possible harm of drugs given for a long-lasting period.

“Adverse events associated with antiepileptic drugs are a particular concern for children, women considering pregnancy, pregnant women, and the elderly. Therefore, the decision to start antiepileptic drug treatment following a first unprovoked seizure should be individualized and based on patient preference, clinical, legal, and socio-cultural factors.”

Links:

Cochrane review

MA Leone. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database of Systematic Reviews. Published online May 6 2016

Clinical News

August 18 2017 GPs lack familiarity with current physical activity guidelines, a survey has found. Only 20% of the 1,013 GPs in England responding to the survey “were broadly or very familiar with the...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...